Protein-rich Diet and NAFLD in Bariatric Surgery

NCT ID: NCT02400099

Last Updated: 2015-03-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Randomized, single-blind, trial to determine whether a high-protein, low calorie diet is more effective than a control low calorie diet in improving the metabolic and histologic abnormalities in patients with Non-alcoholic Fatty Liver Disease undergoing bariatric surgery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obesity Non-alcoholic Fatty Liver Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

High-protein low calorie diet (HPLC)

900 Kcal; Protein 90 g (39%); CHO 75 g (30%); Lipid 32 g (31%)

Group Type ACTIVE_COMPARATOR

High-protein low calorie diet

Intervention Type DIETARY_SUPPLEMENT

Anthropometrical measurements

Intervention Type OTHER

Body composition

Intervention Type OTHER

8-h metabolic profile

Intervention Type OTHER

Liver biopsy

Intervention Type OTHER

Control low calorie diet (CLC)

900 Kcal; Protein. 50 g (22%); CHO 119 g (48%); Lipid 31 g (30%)

Group Type PLACEBO_COMPARATOR

Control low calorie diet

Intervention Type DIETARY_SUPPLEMENT

Anthropometrical measurements

Intervention Type OTHER

Body composition

Intervention Type OTHER

8-h metabolic profile

Intervention Type OTHER

Liver biopsy

Intervention Type OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

High-protein low calorie diet

Intervention Type DIETARY_SUPPLEMENT

Control low calorie diet

Intervention Type DIETARY_SUPPLEMENT

Anthropometrical measurements

Intervention Type OTHER

Body composition

Intervention Type OTHER

8-h metabolic profile

Intervention Type OTHER

Liver biopsy

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Morbidly obese subjects with a BMI \>40 kg/m2 who are eligible for bariatric surgery and have accepted to undergo RYGB
* Weight stable for at least 6 months before the study (+/- 5 kg within the previous 6 months)
* Stable medication
* Provision of informed consent

Exclusion Criteria

* Patients not eligible for laparoscopic RYGB
* Incapacity to give a valid informed consent or unwilling to give the consent
* Pregnancy or lactating
* Type 2-diabetes mellitus
* Significant illness within the two weeks preceding surgery, as judged by the physician.
* Obvious infection (bacteria, virus etc)
* Major cardiovascular disease
* Major gastrointestinal, respiratory, or any hormonal disorders
* History of drug addiction and/or alcohol use
* Suspected or confirmed poor compliance
* Alcohol consumption of \> 20 g per day in the case of women and \> 30 g per day in the case of men for at least 3 consecutive months during the previous 5 years
* Presence of hepatitis C or frank cirrhosis.
Minimum Eligible Age

20 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Federico II University

OTHER

Sponsor Role collaborator

Catholic University of the Sacred Heart

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Geltrude Mingrone

Associate Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Catholic University School of Medicine

Rome, , Italy

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Italy

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Geltrude Mingrone, Professor

Role: CONTACT

0630154395 ext. 0039

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

UCSC-2015

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.